Teiji Kuzuya

Fujita Health University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (7)

Takumi Kawaguchi

Kurume University School of Medicine

JAPAN

View details

Takuya Ishikawa

Nagoya University Hospital

JAPAN

View details

Shinya Yokoyama

Nagoya University

JAPAN

View details

Yoshiki Hirooka

Nagoya University Graduate School of Medicine

JAPAN

View details

Kohei Funasaka

Fujita Health University

JAPAN

View details

Yutaro Kato

Fujita Health University

JAPAN

View details

Ayako Watanabe

Fujita Health University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Teiji Kuzuya

Research Interests

Explore related searches

Contact this professor

Articles (15)

Rechallenge of Atezolizumab Plus Bevacizumab Therapy in Patients With Unresectable Hepatocellular Carcinoma

Efficacy of 1-Kestose Supplementation in Patients with Pancreatic Ductal Adenocarcinoma: A Randomized Controlled Pilot Study

Early Changes in Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin Are Useful Predictors of Antitumor Response to Durvalumab Plus Tremelimumab Therapy for Advanced Hepatocellular Carcinoma

Characteristics and Prognosis of Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab Combination Therapy Who Achieved Complete Response

A Proposal for a Simple Subclassification of Advanced Hepatocellular Carcinoma in Systemic Treatment

Clinical Outcomes of Cabozantinib in Patients Previously Treated with Atezolizumab/Bevacizumab for Advanced Hepatocellular Carcinoma—Importance of Good Liver Function and Good Performance Status

Current Status of the Diagnosis of Early-Stage Pancreatic Ductal Adenocarcinoma

Polymyalgia rheumatica during combination therapy with atezolizumab plus bevacizumab for advanced hepatocellular carcinoma

Pretreatment Proteinuria Predicts the Prognosis of Patients Receiving Systemic Therapy for Unresectable Hepatocellular Carcinoma

The Clinical Impact of Hepatic Arterial Infusion Chemotherapy New-FP for Hepatocellular Carcinoma with Preserved Liver Function

MicroRNA Profile of Human Small Intestinal Tumors Compared to Colorectal Tumors

Early Changes in Alpha-Fetoprotein Are a Useful Predictor of Efficacy of Atezolizumab plus Bevacizumab Treatment in Patients with Advanced Hepatocellular Carcinoma

Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma

The Role of Endoscopic Ultrasound in the Diagnosis of Gallbladder Lesions

Rapid increase of platelet counts during antiviral therapy in patients with hepatitis C virus infection

Collaborators (7)

Takumi Kawaguchi

Takuya Ishikawa

Shinya Yokoyama

Yoshiki Hirooka

Kohei Funasaka

Yutaro Kato

Ayako Watanabe

Make your next move.